Snake Venom Viper Peptide as Aesthetic Agent: A Review of its Potential Use
International Journal of Innovative Science and Research Technology · 07.03.2026 · 2867
DOI: 10.38124/ijisrt/26feb1454 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 07.03.2026. Verfasst von Leroy Lucano Sompotan. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
The integration of animal-derived toxins into the aesthetic pharmacopeia represents a transformative shift in the management of cutaneous senescence and structural skin dysfunction. This review evaluates the emergence of snake venomderived peptides, specifically those mimicking the neuromuscular blocking activities of viper venom, as high-performance aesthetic agents. Central to this analysis is the evolution of "venomics" facilitated by advancements in mass spectrometry, genomics, and proteomics. By synthesizing clinical data from venom-derived pharmaceutical trials, including studies on alfimeprase and cenderitide, the safety profile and receptor specificity of these compounds are established. The analysis reveals a significant commercial shift toward neurocosmetics, with synthetic viper-mimetic peptides now occupying a substantial portion of the premium skincare market.
Zitieren
APA
Sompotan, L. L. (2026). Snake Venom Viper Peptide as Aesthetic Agent: A Review of its Potential Use. International Journal of Innovative Science and Research Technology, 2867. https://doi.org/10.38124/ijisrt/26feb1454
Vancouver
Sompotan LL. Snake Venom Viper Peptide as Aesthetic Agent: A Review of its Potential Use. International Journal of Innovative Science and Research Technology. 2026:2867. doi:10.38124/ijisrt/26feb1454
BibTeX
@article{Sompotan2026,
author = {Sompotan, Leroy Lucano},
title = {Snake Venom Viper Peptide as Aesthetic Agent: A Review of its Potential Use},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {2867},
doi = {10.38124/ijisrt/26feb1454}
}
EUVIMED